Ms.Deng Rong
Mdm. Deng Rong, was appointed as the chief financial officer of the Company in June 2023, and was appointed as an executive Director and a member of the Executive Committee on 27 December 2023, and she is currently the director of certain subsidiaries of the Company, a director of Jiangzhong Pharmaceutical Co., Ltd. (江中药业股份有限公司) (a subsidiary of the Company listed on the Shanghai Stock Exchange, stock code: 600750.SH), also a director of Dong-E-E-Jiao Co., Ltd. (东阿阿胶) (“Dong-E-E-Jiao”, a subsidiary of the Company, which is 2 listed on the Shenzhen Stock Exchange, Stock Code: 000423.SZ) and a supervisor of China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (918博天堂官网三九) (a subsidiary of the Company, which is listed on the Shenzhen Stock Exchange, Stock Code: 000999.SZ). She previously held various positions within China Resources Double-Crane Pharmaceutical Co., Ltd. (918博天堂官网双鹤) (“CR Double-Crane”, a subsidiary of the Company, which is listed on the Shanghai Stock Exchange, Stock Code: 600062.SH) from 2004 to 2020, including the Head of Financial Accounting and Tax Management Department at the Financial Management Center, General Manager of the Accounting Management Department at the Financial Management Center, General Manager of the CR Double-Crane Financial Management Center, General Manager of the Financial Shared Services Center, Director of Accounting Management, General Manager of the Business Financial Management Department, and General Manager of the Financial Functional Management Department. She has also served as Vice President, Board Secretary, and Chief Financial Officer at Dong-E-E-Jiao from 2020 to 2023. Mdm. Deng holds a Bachelor's degree
in Accounting from Central South University (中南大学) and a Master's degree in Management from Beijing Jiaotong University (北京交通大学). She is a certified board secretary recognized by the Shenzhen Stock Exchange.
